Merrimack Pharmaceuticals, Inc.
NASDAQ:MACK
15.145 (USD) • At close May 17, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 144.273 | 89.258 | 102.756 | 47.786 | 48.921 | 34.215 | 20.305 | 2.148 |
| Kosten van de omzet
| 0 | 0.445 | 0 | 0 | 2.228 | 0 | 0 | 6.912 | 0.046 | 0 | 0 | 0 | 100.63 | 58.278 | 37.658 |
| Brutowinst
| 0 | -0.445 | 0 | 0 | -2.228 | 0 | 0 | 137.361 | 89.212 | 102.756 | 47.786 | 48.921 | -66.415 | -37.973 | -35.51 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.952 | 0.999 | 1 | 1 | 1 | -1.941 | -1.87 | -16.532 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 11.1 | 49.974 | 67.314 | 160.917 | 160.988 | 138.495 | 147.139 | 125.858 | 0.365 | 0 | 0 |
| Algemene en administratieve kosten
| 2.176 | 2.174 | 2.616 | 5.012 | 16.169 | 15.601 | 28.452 | 0 | 0 | 30.517 | 21.187 | 15.805 | 8.836 | 0 | 0 |
| Verkoop- en marketingkosten
| 2.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.618 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 2.176 | 2.174 | 2.616 | 5.012 | 16.169 | 15.601 | 28.452 | 80.729 | 57.595 | 30.517 | 21.187 | 15.805 | 14.454 | 11.381 | 12.178 |
| Overige kosten
| 0 | 0 | 0 | -0.191 | 0.37 | -3.23 | -1.433 | -43.377 | -18.216 | -17.303 | -10.145 | 0.988 | 34.163 | 0 | 0 |
| Bedrijfskosten
| 2.176 | 2.174 | 2.616 | 5.012 | 27.269 | 65.575 | 95.766 | 241.646 | 218.583 | 169.012 | 168.326 | 141.663 | 14.454 | 11.381 | 12.178 |
| Bedrijfsresultaat
| -2.176 | -1.729 | -2.472 | -2.873 | -22.359 | -65.575 | -95.766 | -110.141 | -129.571 | -66.256 | -120.54 | -92.742 | -80.869 | -49.176 | -47.688 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.763 | -1.452 | -0.645 | -2.522 | -1.896 | -2.364 | -2.422 | -22.201 |
| Totaal overige inkomsten en kosten netto
| 1.007 | 0.188 | 0.02 | -0.141 | -0.381 | -3.23 | 11.118 | -49.233 | -18.216 | -17.303 | -10.145 | 0.988 | 1.15 | 2.847 | 0.041 |
| Inkomen voor belasting
| -1.169 | -1.541 | -2.452 | -3.014 | -22.74 | -68.462 | -118.403 | -153.518 | -147.787 | -83.559 | -130.685 | -91.754 | -79.676 | -50.159 | -52.475 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.064 | -1.656 | -0.813 | -2.735 | -1.876 | -2.329 | -2.47 | -24.43 |
| Belastingkosten
| 0.012 | 0.003 | 0.003 | 0.014 | -1.473 | -7.695 | -42.399 | -13.224 | -3.918 | -3.491 | -2.349 | -4.141 | -0.44 | 3.671 | -3.402 |
| Nettowinst
| -1.181 | -1.544 | -2.455 | -3.028 | -21.267 | -40.506 | 472.028 | -151.74 | -147.957 | -83.291 | -130.925 | -91.277 | -79.223 | -50.104 | -49.073 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.052 | -1.658 | -0.811 | -2.74 | -1.866 | -2.315 | -2.468 | -22.846 |
| WPA (Winst Per Aandeel)
| -0.083 | -0.11 | -0.18 | -0.23 | -1.59 | -3.04 | 35.67 | -12.11 | -13.29 | -7.98 | -13.24 | -12.53 | -8.57 | -44.17 | -43.26 |
| Verwaterde WPA
| -0.083 | -0.11 | -0.18 | -0.23 | -1.59 | -3.04 | 35.67 | -12.11 | -13.29 | -7.98 | -13.24 | -12.53 | -8.57 | -44.17 | -43.26 |
| EBITDA
| -2.176 | -2.619 | -2.76 | -5.153 | -23.894 | -63.432 | -91.083 | -98.429 | -129.371 | -66.256 | -120.54 | -92.742 | -75.487 | -44.901 | -44.852 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.682 | -1.449 | -0.645 | -2.522 | -1.896 | -2.206 | -2.211 | -20.881 |